Skip to content
The Nexus
DossierENTITY

Department of Drug Registration

Coverage of Department of Drug Registration in the Nexus archive.

Earliest in view: Jul 13 · 10:15 UTCMost recent: Jul 13 · 10:15 UTC
Co-mentioned in this coverage
Lan Gongtaoperson1National Medical Products Administrationorganization1AI-powered candidatestopic1cross-border dealstopic1innovative drugstopic1Chinaplace1
Recent coverage
  • BUSINESSJul 13 · 10:15 UTCSCMP CHINA
    China’s drug industry pivots to AI-powered candidates to drive next wave of deals

    China's cross-border deals for innovative drugs reached $110 billion in H1 2026, with the industry now focusing on AI-powered candidates to drive future transactions. China holds 30% of globally developed new drugs, ranking second worldwide, according to Lan Gongtao from the National Medical Products Administration.

Department of Drug Registration · Dossier · The Nexus